Actively Recruiting

Phase 4
Age: 2Years - 6Years
All Genders
NCT07427446

Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium

Led by Kasr El Aini Hospital · Updated on 2026-02-27

50

Participants Needed

1

Research Sites

56 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Fifty children undergoing heart catheterization without local anesthesia in the skin will be randomly divided into two groups. Group DM (Dexmedetomidine + Midazolam) and Group KM (Ketamine + Midazolam)

CONDITIONS

Official Title

Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium

Who Can Participate

Age: 2Years - 6Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Scheduled for elective cardiac catheterization under general anesthesia.
Not Eligible

You will not qualify if you...

  • Neurological disorder, psychiatric disease, or current psychoactive medication.
  • Allergy.
  • Significant systemic comorbidities.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Kasralainy Hospital

Cairo, Egypt

Actively Recruiting

Loading map...

Research Team

A

Ahmed Elhaddad, Ass.prof.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here